NCT05752968View on ClinicalTrials.gov

Elevated Levels of Antibodies to Endotoxin Core in Hemodialysis Patients With Peripheral Artery Disease

CompletedOBSERVATIONAL

Enrollment

155

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

EndotoxemiaPeripheral Arterial Disease

Trial Locations (1)

Unknown

Tungs' Taichung MetroHarbour Hospital, Taichung

All Listed Sponsors

lead

Tungs' Taichung Metroharbour Hospital

OTHER

NCT05752968 - Elevated Levels of Antibodies to Endotoxin Core in Hemodialysis Patients With Peripheral Artery Disease | Biotech Hunter | Biotech Hunter